Benefits and risk of screening for atrial fibrillation (modified from Guidelines 202010)
Benefits . | Risk . | Exploring convergence points . |
---|---|---|
Clinical Prevention of: Stroke using OAC if indicated
| Stress and anxiety before and after the test. Possible divergence of patient interest vs. healthcare provider. | Evaluate patient’s interest, values, goals, and preferences before proposing a screening test. Clarification that patient decision will be respected. Clarify possible misperceptions regarding to the procedure. |
Biological Reversal/prevention:
| False positives and ECG misinterpretation may promote overdiagnosis and overtreatment and also complications secondary to a positive test. Risk of harm and increase of cost. Bleeding secondary to OAC treatment. | Establish an open discussion regarding the nature of AF and potential negative and positive aspects of the procedure. |
Benefits . | Risk . | Exploring convergence points . |
---|---|---|
Clinical Prevention of: Stroke using OAC if indicated
| Stress and anxiety before and after the test. Possible divergence of patient interest vs. healthcare provider. | Evaluate patient’s interest, values, goals, and preferences before proposing a screening test. Clarification that patient decision will be respected. Clarify possible misperceptions regarding to the procedure. |
Biological Reversal/prevention:
| False positives and ECG misinterpretation may promote overdiagnosis and overtreatment and also complications secondary to a positive test. Risk of harm and increase of cost. Bleeding secondary to OAC treatment. | Establish an open discussion regarding the nature of AF and potential negative and positive aspects of the procedure. |
Benefits and risk of screening for atrial fibrillation (modified from Guidelines 202010)
Benefits . | Risk . | Exploring convergence points . |
---|---|---|
Clinical Prevention of: Stroke using OAC if indicated
| Stress and anxiety before and after the test. Possible divergence of patient interest vs. healthcare provider. | Evaluate patient’s interest, values, goals, and preferences before proposing a screening test. Clarification that patient decision will be respected. Clarify possible misperceptions regarding to the procedure. |
Biological Reversal/prevention:
| False positives and ECG misinterpretation may promote overdiagnosis and overtreatment and also complications secondary to a positive test. Risk of harm and increase of cost. Bleeding secondary to OAC treatment. | Establish an open discussion regarding the nature of AF and potential negative and positive aspects of the procedure. |
Benefits . | Risk . | Exploring convergence points . |
---|---|---|
Clinical Prevention of: Stroke using OAC if indicated
| Stress and anxiety before and after the test. Possible divergence of patient interest vs. healthcare provider. | Evaluate patient’s interest, values, goals, and preferences before proposing a screening test. Clarification that patient decision will be respected. Clarify possible misperceptions regarding to the procedure. |
Biological Reversal/prevention:
| False positives and ECG misinterpretation may promote overdiagnosis and overtreatment and also complications secondary to a positive test. Risk of harm and increase of cost. Bleeding secondary to OAC treatment. | Establish an open discussion regarding the nature of AF and potential negative and positive aspects of the procedure. |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.